SEGLENTIS

Kowa Pharmaceuticals America, Inc.🇺🇸 United States

FDA Page

Effective Date: Mar 5, 2024
Approval ID: cf2c8436-a9f3-473c-e053-2a95a90a1123
Products: 1 registered
Version: 4

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SEGLENTIS safely and effectively. See full prescribing information for SEGLENTIS. SEGLENTIS (celecoxib and tramadol hydrochloride) tablets, for oral use, C-IV Initial U.S. Approval: 2021

Quick Stats

Total Products1

Labelers2

Label Sections39

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.